Investigation of New Morpholino Oligomers to Increase Survival Motor Neuron Protein Levels in Spinal Muscular Atrophy

Spinal muscular atrophy (SMA) is an autosomal-recessive childhood motor neuron disease and the main genetic cause of infant mortality. SMA is caused by deletions or mutations in the survival motor neuron 1 (SMN1) gene, which results in SMN protein deficiency. Only one approved drug has recently beco...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Agnese Ramirez, Sebastiano G. Crisafulli, Mafalda Rizzuti, Nereo Bresolin, Giacomo P. Comi, Stefania Corti, Monica Nizzardo
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI AG 2018-01-01
Edice:International Journal of Molecular Sciences
Témata:
spinal muscular atrophy
morpholino
therapy
On-line přístup:http://www.mdpi.com/1422-0067/19/1/167
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky